Acute Respiratory Failure As A Manifestation Of Eosinophilia-myalgia Syndrome Associated With L-tryptophan Intake [insuficiência Respiratória Aguda Como Manifestaçã O Da Síndrome De Eosinofilia-mialgia Associada à Ingestão De L-triptofano]

dc.creatorGrangeia T.D.A.G.
dc.creatorSchweller M.
dc.creatorPaschoal I.A.
dc.creatorZambon L.
dc.creatorPereira M.C.
dc.date2007
dc.date2015-06-30T18:52:50Z
dc.date2015-11-26T14:39:14Z
dc.date2015-06-30T18:52:50Z
dc.date2015-11-26T14:39:14Z
dc.date.accessioned2018-03-28T21:44:47Z
dc.date.available2018-03-28T21:44:47Z
dc.identifier
dc.identifierJornal Brasileiro De Pneumologia. , v. 33, n. 6, p. 747 - 751, 2007.
dc.identifier18063713
dc.identifier10.1590/S1806-37132007000600021
dc.identifierhttp://www.scopus.com/inward/record.url?eid=2-s2.0-41649113421&partnerID=40&md5=b654f724ee2464d77ef77813c7948c07
dc.identifierhttp://www.repositorio.unicamp.br/handle/REPOSIP/105216
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/105216
dc.identifier2-s2.0-41649113421
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1249915
dc.descriptionEosinophilia-myalgia syndrome was described in 1989 in patients who presented progressive and incapacitating myalgia and eosinophilia in blood, fluids and secretions. Most patients report previous L-tryptophan intake. Respiratory manifestations are found in up to 80% of the cases, occasionally as the only manifestation. Treatment includes drug discontinuation and administration of corticosteroids. Here, we describe the case of a 61-year-old female admitted with acute respiratory failure after using L-tryptophan, hydroxytryptophan and other drugs. The patient presented eosinophilia, together with elevated eosinophil counts in the bronchoalveolar lavage and pleural effusion. After discontinuation of the drugs previously used, corticosteroids were administered, resulting in clinical and radiological improvement within just a few days.
dc.description33
dc.description6
dc.description747
dc.description751
dc.descriptionAhmed MM, Mubashir E, Sairam S, Lisse JR. Eosinophilia-Myalgia Syndrome. [monograph on the Internet]. e-medicine
dc.descriptionWebMD
dc.descriptionc1996-2006 [cited 2006 May 5]. Available from: http://www.emedicine.com/med/topic693.htm#section~workupHerrick, M.K., Chang, Y., Horoupian, D.S., Lombard, C.M., Adornato, B.T., L-tryptophan and the eosinophilia-myalgia syndrome: Pathologic findings in eight patients (1991) Hum Pathol, 22 (1), pp. 12-21
dc.descriptionTazelaar, H.D., Myers, J.L., Drage, C.W., King Jr, T.E., Aguayo, S., Colby, T.V., Pulmonary disease associated with L-tryptophan-induced eosinophilic myalgia syndrome. Clinical and pathologic features (1990) Chest, 97 (5), pp. 1032-1036
dc.descriptionCampagna, A.C., Blanc, P.D., Criswell, L.A., Clarke, D., Sack, K.E., Gold, W.M., Golden, J.A., Pulmonary manifestations of the eosinophilia-myalgia syndrome associated with tryptophan ingestion (1992) Chest, 101 (5), pp. 1274-1281
dc.descriptionBallone, G.J., (2005) Serotonina. [monograph on the Internet] Psiqweb
dc.descriptionc, , http://virtualpsy.locaweb.com.br/index.php?sec=61&art=295, cited 2006 Oct 4, Available from
dc.descriptionShapiro, S., L-tryptophan and eosinophilia-myalgia syndrome (1994) Lancet, 344 (8925), pp. 817-819
dc.descriptionShapiro, S., Epidemiologic studies of the association of L-tryptophan with the eosinophilia-myalgia syndrome: A critique (1996) J Rheumatol Suppl, 46, pp. 44-58. , discussion 58-9
dc.descriptionClauw, D.J., Pincus, T., The eosinophilia-myalgia syndrome: What we know, what we think we know, and what we need to know (1996) J Rheumatol Suppl, 46, pp. 2-6
dc.descriptionde Kerviler, E., Trédaniel, J., Revlon, G., Groussard, O., Zalcman, G., Ortoli, J.M., Fluoxetin-induced pulmonary granulomatosis (1996) Eur Respir J, 9 (3), pp. 615-617
dc.descriptionWilliamson, M.R., Edison, M., Rosenberg, R.D., Williamson, S.L., Eosinophilia-myalgia syndrome: Findings on chest radiographs in 18 patients (1991) Radiology, 180 (3), pp. 849-851
dc.descriptionHertzman, P.A., Criteria for the definition of the eosinophilia-myalgia syndrome (1996) J Rheumatol Suppl, 46, pp. 7-12
dc.descriptionPincus, T., Eosinophilia-myalgia syndrome: Patient status 2-4 years after onset (1996) J Rheumatol Suppl, 46, pp. 19-24. , discussion 24-5
dc.descriptionMargolin, L., Non-L-tryptophan related eosinophilia-myalgia syndrome with hypoproteinemia and hypoalbuminemia (2003) J Rheumatol, 30 (3), pp. 628-629
dc.descriptionSilver, R.M., Pathophysiology of the eosinophilia-myalgia syndrome (1996) J Rheumatol Suppl, 46, pp. 26-36
dc.descriptionSwygert, L.A., Maes, E.F., Sewell, L.E., Miller, L., Falk, H., Kilbourne, E.M., Eosinophilia-myalgia syndrome. Results of national surveillance (1990) JAMA, 264 (13), pp. 1698-1703
dc.descriptionClinical spectrum of eosinophilia-myalgia syndrome - California (1990) MMWR Morb Mortal Wkly Rep, 39 (6), pp. 89-91. , Centers for Disease Control CDC
dc.descriptionBanner, A.S., Borochovitz, D., Acute respiratory failure caused by pulmonary vasculitis after L-tryptophan ingestion (1991) Am Rev Respir Dis, 143 (3), pp. 661-664
dc.descriptionStrumpf, I.J., Drucker, R.D., Anders, K.H., Cohen, S., Fajolu, O., Acute eosinophilic pulmonary disease associated with the ingestion of L-tryptophan-containing products (1991) Chest, 99 (1), pp. 8-13
dc.languagept
dc.languageen
dc.publisher
dc.relationJornal Brasileiro de Pneumologia
dc.rightsaberto
dc.sourceScopus
dc.titleAcute Respiratory Failure As A Manifestation Of Eosinophilia-myalgia Syndrome Associated With L-tryptophan Intake [insuficiência Respiratória Aguda Como Manifestaçã O Da Síndrome De Eosinofilia-mialgia Associada à Ingestão De L-triptofano]
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución